MetLife Investment Advisors »

Prime Medicine shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $188k 21k 8.86
2023-09-30 $203k 21k 9.54
2023-06-30 $312k 21k 14.65
2023-03-31 $75k 6.1k 12.30
2022-12-31 $113k 6.1k 18.58